Skip to main content
. 2020 Dec 8;11:598939. doi: 10.3389/fphar.2020.598939

FIGURE 4.

FIGURE 4

AT-I regulated TLR4/NF-κB signaling pathway in breast cancer cells. (A, B) The effects of AT-I on TLR4/NF-κB signaling pathway were measured by western blot assay. (C, D) The levels of TNF-α, IL-6 and IL-1β in the supernatants of cells were measured by ELISA assay. Significant differences between different groups were indicated as *p < 0.05, **p < 0.01, vs. the 0 μM control group or the LPS treated control group, n = 3.